Jones Lang LaSalle Incorporated
$15.76B- Market cap
- $16.35B
- Debt
- +-$200.00K
- Cash
- −$599.10M
Capital structure 100% equity / -0% debt · EV / Revenue 0.60x · EV / EBITDA 10.71x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: JLL stock price at premium vs EVH $355.48 current versus $145.37 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EVH's multiple
Implied fair value · at JLL's multiple
Snapshot Sep 8, 2026, 2:39 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: JLL FY 2025 (ended Dec 31, 2025) · EVH FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 100% equity / -0% debt · EV / Revenue 0.60x · EV / EBITDA 10.71x
Capital structure 33% equity / 67% debt · EV / Revenue 0.69x
JLL carries the larger enterprise value at $15.76B against $1.30B; JLL trades on the lower EV / Revenue multiple (0.60x vs 0.69x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Jones Lang LaSalle Incorporated · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Evolent Health, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
-0.00x
2.34x
Net debt / EBITDA
Leverage against operating earnings
-0.41x
-2.11x
Cash and equivalents
Liquid reserves on the balance sheet
$599.10M
$151.86M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CBRE GROUP, INC.
JLL vs CBRE
NEWMARK GROUP, INC.
JLL vs NMRK
Kennedy-Wilson Holdings, Inc.
JLL vs KW
Marcus & Millichap, Inc.
JLL vs MMI
Cigna Group
JLL vs CI
MOLINA HEALTHCARE, INC.
JLL vs MOH
Teladoc Health, Inc.
JLL vs TDOC
CLOVER HEALTH INVESTMENTS, CORP. /DE
JLL vs CLOV
UNITEDHEALTH GROUP INC
JLL vs UNH
-$200.00K
$970.54M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.